Ancylostomiasis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
 
(26 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Infobox_Disease |
__NOTOC__
  Name          = {{PAGENAME}} |
{{Ancylostomiasis}}
  Image          = |
  Caption        = |
  DiseasesDB    = |
  ICD10          = {{ICD10|B|76|0|b|65}} |
  ICD9          = {{ICD9|126.9}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = ped |
  eMedicineTopic = 96 |
  MeshID        = D000724 |
}}
{{SI}}


{{EH}}
{{CMG}} {{AE}} {{Kalpana Giri}}


'''Ancylostomiasis''' is the condition of infection by [[Ancylostoma]] [[hookworm]]s.
==[[Ancylostomiasis overview|Overview]]==


==Diagnosis==
==[[Ancylostomiasis historical perspective|Historical Perspective]]==
They commonly infect the skin, eyes, and viscera in humans.


* [[Ancylostoma brasiliensis]] causes [[cutaneous larva migrans]].
==[[Ancylostomiasis classification|Classification]]==


* [[Toxocara]] causes [[visceral larva migrans]]. <ref> {{cite web | url=http://cancerweb.ncl.ac.uk/cgi-bin/omd?larva+migrans | title=Definition: larva migrans | accessdate=10-30-2008 }} </ref>
==[[Ancylostomiasis pathophysiology|Pathophysiology]]==


==Causes==
==[[Ancylostomiasis causes|Causes]]==
The infection is usually contracted by persons walking barefoot over
contaminated soil.  In penetrating the skin, the larvae may cause an allergic
reaction.  It is from the itchy patch at the site of entry that the early
infection gets its nickname "ground itch". Once larvae have broken through the skin,
they enter the bloodstream and are carried to the lungs.  (Unlike ascarids,
however, hookworms do not usually cause pneumonia.) The larvae migrate from
the lungs up the windpipe to be swallowed and carried back down to the
intestine.  If humans come into contact with larvae of the dog hookworm or the
cat hookworm, or of certain other hookworms that do not infect humans, the
larvae may penetrate the skin.The larvae are unable to complete their
migratory cycle in humans.  Instead, the larvae migrate just below the skin
producing snake-like markings.  This is referred to as a creeping eruption or
cutaneous larva migrans.
<ref> {{cite web |
url=http://www.comeunity.com/adoption/health/parasites/hookworm-NIH.html |
title=Hookworm | accessdate=10-30-2008 }} </ref>


==Symptoms==
==[[Ancylostomiasis differential diagnosis|Differentiating Ancylostomiasis from other Diseases]]==
In children (or adults) who walk barefoot, the hookworm can penetrate the sole
of the foot and cause a lesion. The larva will then begin to mature while it
moves towards the intestines. As in dogs, the hookworm will attach to the
intestinal wall. Humans who have become infected will show symptoms of
intestinal bleeding, abdominal pains, anemia, sever diarrhea and malnutrition.
<ref> {{cite web | url=http://www.essortment.com/all/hookwormdogshu_rdhu.htm |
title=Hookworms in dogs and humans | accessdate=10-30-2008 }} </ref>


==Treatment==
==[[Ancylostomiasis epidemiology and demographics|Epidemiology and Demographics]]==
The drug of choice for the treatment of hookworm disease is mebendazole which
is effective against both species, and in addition, will remove the intestinal
worm Ascaris also, if present. The drug is very efficient, requiring only a
single dose and is inexpensive, the perfect drug. However, treatment requires
more than giving the anthelmintic, the patient should also receive dietary
supplements to improve their general level of health, in particular iron
supplementation is very important. Iron is an important constituent of a
multitude of enzyme systems involved in energy metabolism, DNA synthesis and
drug detoxification.


As mentioned earlier larval migrans or as it is also known, creeping eruption,
==[[Ancylostomiasis risk factors|Risk Factors]]==
is also a very uncomfortable symptom of this disease, and can also be caused
by invasion of hookworms from other animals such as cats and dogs. Because
they are in an abnormal host they do not mature to adults but instead migrate
through the skin until killed by the host's inflammatory response. This causes
local intense itching. Topical treatment with thiabendazole ointment is very
effective in controlling this condition.


Control of this parasite should be directed against reducing the level of
==[[Ancylostomiasis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
environmental contamination. Treatment of heavily infected individuals is one
way to reduce the source of contamination (one study has estimated that 60% of
the total worm burden resides in less than 10% of the population). Other
obvious methods are to improve sanitary condition, e.g. latrines, but also
convincing people to use them by maintaining them in a serviceable form making
them conducive to use. Hookworms still account for high proportion of
debilitating disease in the tropics and 50-60,000 deaths per year can be
attributed to this disease.
<ref> {{cite web | url=http://www.earthtym.net/ref-hookworms.htm |
title=Hookworms: Ancylostoma spp. and Necator spp. |
accessdate=10-30-2008}}</ref>


==References==
==Diagnosis==
{{reflist}}
[[Ancylostomiasis history and symptoms| History and Symptoms]] | [[Ancylostomiasis physical examination | Physical Examination]] | [[Ancylostomiasis laboratory findings|Laboratory Findings]] | [[Ancylostomiasis other imaging findings|Other Imaging Findings]] | [[Ancylostomiasis other diagnostic studies|Other Diagnostic Studies]]


{{Helminthiases}}
==Treatment==
 
[[Ancylostomiasis medical therapy|Medical Therapy]] |  [[Ancylostomiasis surgery|Surgery]] | [[Ancylostomiasis primary prevention|Primary Prevention]] | [[Ancylostomiasis secondary prevention|Secondary Prevention]] | [[Ancylostomiasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Ancylostomiasis future or investigational therapies|Future or Investigational Therapies]]
[[Category:Parasitic diseases]]
{{SIB}}
[[pl:Ankylostomatoza]]


{{WH}}
==Case Studies==
{{WS}}
[[Ancylostomiasis case study one|Case#1]]

Latest revision as of 20:45, 30 August 2021

Ancylostomiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ancylostomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Endoscopy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ancylostomiasis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ancylostomiasis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ancylostomiasis

CDC on Ancylostomiasis

Ancylostomiasis in the news

Blogs on Ancylostomiasis

Directions to Hospitals Treating Ancylostomiasis

Risk calculators and risk factors for Ancylostomiasis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalpana Giri, MBBS[2]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ancylostomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case#1